LAB Earnings — Standard BioTools Inc. Common Stock Post-ER Performance | BigEarnings
LAB — Standard BioTools Inc. Common Stock
XNAS · Healthcare · Medical Devices
Price$1.15
Market Cap$448.9M
P/E5.7
52W Range$0.87 – $1.72
Next Earnings2026-08-10
About Standard BioTools Inc. Common Stock
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
